Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.80
-0.04-2.17%
Last update: Oct 12, 3:59 PM
Pulmonx Corp (LUNG) Stock Price, Quote, News & History
LUNGNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Pulmonx (NASDAQ:LUNG) through any online brokerage.
Other companies in Pulmonx’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Pulmonx has a consensus price target of $6.21.
The stock price for Pulmonx (NASDAQ: LUNG) is $1.805 last updated October 12, 2026 at 3:59 PM EDT.
There are no upcoming dividends for Pulmonx.
Pulmonx does not have any upcoming earnings scheduled.
There is no upcoming split for Pulmonx.
Pulmonx is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
